Showing results (341-350 of 367) with videos related to

Sort By:
Pageof 37
Leukemia|October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment responseMeagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Cancer Discovery|August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational StudyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Myelodysplastic syndromes, version 2.2015Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023
An observation-based, reduced-form model for oxidation in the remote marine troposphereColleen B Baublitz, Arlene M Fiore, Sarah M Ludwig, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020Pamela Sue Becker, Elizabeth A Griffiths, Laura M Alwan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022Elizabeth A Griffiths, Vivek Roy, Laura Alwan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
Pageof 37